Cell Cycle-Dependent Kinase Cdk9 Is a Postexposure Drug Target against Human Adenoviruses.

Human adenoviruses (HAdVs) infect respiratory, gastrointestinal, and urinary tracts and give rise to eye infections and epidemic keratoconjunctivitis (EKC). They persist in lymphoid tissue and cause morbidity and mortality in immunocompromised people. Treatments with significant postexposure efficacy are not available. Here, we report that inhibition of the cell cycle-dependent kinase 9 (Cdk9) by RNA interference, or the compound flavopiridol, blocked infections with HAdV-C2/5, EKC-causing HAdV-D8/37, and progeny formation in human corneal epithelial and cancer cells. Flavopiridol abrogated the production of the immediate early viral transactivating protein E1A without affecting nuclear import of viral DNA. In morphometric plaque assays, the compound exhibited antiviral efficacy in both pre- and postexposure regimens with therapeutic indexes exceeding 10. The study identifies Cdk9 as a postexposure drug target against adenovirus infections in vitro and suggests that the clinically tested anticancer drug flavopiridol is a candidate for treating adenoviral EKC or adenovirus emergence upon immune suppression.

[1]  R. Bartenschlager,et al.  Editorial: An expanded view of viruses , 2017, FEMS microbiology reviews.

[2]  Yohei Yamauchi,et al.  Principles of Virus Uncoating: Cues and the Snooker Ball , 2016, Traffic.

[3]  I. Sbalzarini,et al.  Infectio: a Generic Framework for Computational Simulation of Virus Transmission between Cells , 2016, mSphere.

[4]  P. Hearing,et al.  E2F/Rb Family Proteins Mediate Interferon Induced Repression of Adenovirus Immediate Early Transcription to Promote Persistent Viral Infection , 2016, PLoS pathogens.

[5]  J. Karp,et al.  Clinical activity of alvocidib (flavopiridol) in acute myeloid leukemia. , 2015, Leukemia research.

[6]  A. Yakimovich,et al.  Plaque2.0—A High-Throughput Analysis Framework to Score Virus-Cell Transmission and Clonal Cell Expansion , 2015, PloS one.

[7]  M. Wenk,et al.  Co-option of Membrane Wounding Enables Virus Penetration into Cells. , 2015, Cell host & microbe.

[8]  Agnieszka K. Witkiewicz,et al.  The history and future of targeting cyclin-dependent kinases in cancer therapy , 2015, Nature Reviews Drug Discovery.

[9]  A. Yakimovich,et al.  Chemical Induction of Unfolded Protein Response Enhances Cancer Cell Killing through Lytic Virus Infection , 2014, Journal of Virology.

[10]  M. Hagiwara,et al.  CDK9 inhibitor FIT-039 prevents replication of multiple DNA viruses. , 2014, The Journal of clinical investigation.

[11]  T. Lion.  Adenovirus Infections in Immunocompetent and Immunocompromised Patients , 2014, Clinical Microbiology Reviews.

[12]  U. Greber,et al.  Innate immunity to adenovirus. , 2014, Human gene therapy.

[13]  Samuel Kilcher,et al.  Tracking viral genomes in host cells at single-molecule resolution. , 2013, Cell host & microbe.

[14]  D. Price,et al.  RNA polymerase II transcription elongation control. , 2013, Chemical reviews.

[15]  G. Chinnadurai,et al.  Adenovirus L-E1A Activates Transcription through Mediator Complex-Dependent Recruitment of the Super Elongation Complex , 2013, Journal of Virology.

[16]  U. Greber,et al.  Adenovirus signalling in entry , 2013, Cellular microbiology.

[17]  D. Matthews,et al.  De novo derivation of proteomes from transcriptomes for transcript and protein identification , 2012, Nature Methods.

[18]  I. Sbalzarini,et al.  Cell-Free Transmission of Human Adenovirus by Passive Mass Transfer in Cell Culture Simulated in a Computer Model , 2012, Journal of Virology.

[19]  U. Greber,et al.  Drifting motions of the adenovirus receptor CAR and immobile integrins initiate virus uncoating and membrane lytic protein exposure. , 2011, Cell host & microbe.

[20]  P. Hearing,et al.  Adenovirus Structural Protein IIIa Is Involved in the Serotype Specificity of Viral DNA Packaging , 2011, Journal of Virology.

[21]  L. Gooding,et al.  Latent Species C Adenoviruses in Human Tonsil Tissues , 2008, Journal of Virology.

[22]  E. De Clercq,et al.  Clinical features and treatment of adenovirus infections , 2008, Reviews in medical virology.

[23]  Anne E Carpenter,et al.  CellProfiler Analyst: data exploration and analysis software for complex image-based screens , 2008, BMC Bioinformatics.

[24]  Stephen Green,et al.  AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies , 2008, Molecular Cancer Therapeutics.

[25]  Atsushi Miyawaki,et al.  Visualizing Spatiotemporal Dynamics of Multicellular Cell-Cycle Progression , 2008, Cell.

[26]  J. Carpenter,et al.  Egress of Light Particles among Filopodia on the Surface of Varicella-Zoster Virus-Infected Cells , 2008, Journal of Virology.

[27]  E. Moler,et al.  CHIR-124, a Novel Potent Inhibitor of Chk1, Potentiates the Cytotoxicity of Topoisomerase I Poisons In vitro and In vivo , 2007, Clinical Cancer Research.

[28]  L. Schang,et al.  Five Years of Progress on Cyclin-Dependent Kinases and other Cellular Proteins as Potential Targets for Antiviral Drugs , 2006, Antiviral chemistry & chemotherapy.

[29]  Anne E Carpenter,et al.  CellProfiler: image analysis software for identifying and quantifying cell phenotypes , 2006, Genome Biology.

[30]  A. Berk,et al.  Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus , 2005, Oncogene.

[31]  W. Plunkett,et al.  Transcription inhibition by flavopiridol: mechanism of chronic lymphocytic leukemia cell death. , 2005, Blood.

[32]  D. Lane,et al.  Seliciclib (CYC202, R-Roscovitine) induces cell death in multiple myeloma cells by inhibition of RNA polymerase II-dependent transcription and down-regulation of Mcl-1. , 2005, Cancer research.

[33]  P. Kinchington,et al.  Prospects for adenovirus antivirals. , 2005, The Journal of antimicrobial chemotherapy.

[34]  S. Frisch,et al.  Adenovirus-5 E1A: paradox and paradigm , 2002, Nature Reviews Molecular Cell Biology.

[35]  J Lederberg,et al.  Infectious History , 2000, Science.

[36]  H. Handa,et al.  An SV40-immortalized human corneal epithelial cell line and its characterization. , 1995, Investigative ophthalmology & visual science.

[37]  Ari Helenius,et al.  Stepwise dismantling of adenovirus 2 during entry into cells , 1993, Cell.

[38]  P. Sharp,et al.  5,6-Dichloro-1-beta-D-ribofuranosylbenzimidazole inhibits transcription elongation by RNA polymerase II in vitro. , 1989, The Journal of biological chemistry.

[39]  J. Richter,et al.  Rapid turnover of adenovirus E1A is determined through a co‐translational mechanism that requires an aminoterminal domain. , 1988, The EMBO journal.

[40]  A. Berk,et al.  Rapid intracellular turnover of adenovirus 5 early region 1A proteins , 1984, Journal of virology.

[41]  F. Nestle,et al.  The alphavbeta5 integrin of hematopoietic and nonhematopoietic cells is a transduction receptor of RGD-4C fiber-modified adenoviruses. , 2003, Gene therapy.